Eric S. Wang

2.7k total citations
18 papers, 806 citations indexed

About

Eric S. Wang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eric S. Wang has authored 18 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Eric S. Wang's work include Protein Degradation and Inhibitors (14 papers), Ubiquitin and proteasome pathways (8 papers) and Multiple Myeloma Research and Treatments (3 papers). Eric S. Wang is often cited by papers focused on Protein Degradation and Inhibitors (14 papers), Ubiquitin and proteasome pathways (8 papers) and Multiple Myeloma Research and Treatments (3 papers). Eric S. Wang collaborates with scholars based in United States, Austria and South Korea. Eric S. Wang's co-authors include Nathanael S. Gray, Eric S. Fischer, Katherine A. Donovan, Tinghu Zhang, Baishan Jiang, Yanke Liang, Radosław P. Nowak, Nicholas Kwiatkowski, André C. Müller and Sophie Bauer and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Journal of Virology.

In The Last Decade

Eric S. Wang

15 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric S. Wang United States	9	699	354	200	94	70	18	806
Weiguo Xiang United States	7	743 1.1×	336 0.9×	235 1.2×	141 1.5×	21 0.3×	16	846
Matthias Brand Germany	11	832 1.2×	379 1.1×	150 0.8×	58 0.6×	30 0.4×	29	977
Alexandru D. Buhimschi United States	5	984 1.4×	430 1.2×	323 1.6×	27 0.3×	70 1.0×	7	1.1k
Ann Katrin Greifenberg Germany	7	641 0.9×	267 0.8×	60 0.3×	102 1.1×	22 0.3×	8	762
Chu Myong Seong South Korea	12	360 0.5×	133 0.4×	119 0.6×	50 0.5×	36 0.5×	30	511
Dhanusha A. Nalawansha United States	10	892 1.3×	395 1.1×	134 0.7×	34 0.4×	15 0.2×	12	971
Tina M. Woo United States	7	620 0.9×	269 0.8×	380 1.9×	17 0.2×	61 0.9×	13	751
Yung Kiang Loh Singapore	4	243 0.3×	152 0.4×	118 0.6×	55 0.6×	143 2.0×	7	389
Marja Dubay United States	11	477 0.7×	168 0.5×	124 0.6×	25 0.3×	59 0.8×	14	567
Ines H. Kaltheuner Germany	7	547 0.8×	190 0.5×	48 0.2×	53 0.6×	15 0.2×	9	624

Countries citing papers authored by Eric S. Wang

Since Specialization

Citations

This map shows the geographic impact of Eric S. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Wang more than expected).

Fields of papers citing papers by Eric S. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric S. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Wang. The network helps show where Eric S. Wang may publish in the future.

Co-authorship network of co-authors of Eric S. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Eric S. Wang. A scholar is included among the top collaborators of Eric S. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric S. Wang. Eric S. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ma, M, Cara R. Schiavon, Elena Rebollo, et al.. (2025). ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC. Nature Chemical Biology. 22(2). 260–273.

Wang, Eric S., et al.. (2025). Synthesis and Structure–Activity Relationships of CRBN-Recruiting ZBTB11 Molecular Glue Degraders. Journal of Medicinal Chemistry. 68(18). 19287–19302.

Ng, Tat Fong, et al.. (2024). Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion. Biomolecules. 14(5). 525–525. 1 indexed citations

Teng, Mingxing, Jie Jiang, Eric S. Wang, et al.. (2023). Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie. 135(18).

Teng, Mingxing, Jie Jiang, Eric S. Wang, et al.. (2023). Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie International Edition. 62(18). e202302364–e202302364. 3 indexed citations

Wang, Eric S., Theresa Manz, Jie Jiang, et al.. (2022). Development of potent and selective degraders of PI5P4Kγ. European Journal of Medicinal Chemistry. 247. 115027–115027. 8 indexed citations

You, Inchul, Katherine A. Donovan, Andrew S. Boghossian, et al.. (2022). Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation. Cell chemical biology. 29(11). 1630–1638.e7. 9 indexed citations

You, Inchul, Katherine A. Donovan, Hong Yue, et al.. (2022). Redirecting the Neo-Substrate Specificity of Cereblon-Targeting PROTACs to Helios. ACS Chemical Biology. 17(9). 2404–2410. 8 indexed citations

Wang, Eric S., Radosław P. Nowak, Jinghua Yuan, et al.. (2021). Acute pharmacological degradation of Helios destabilizes regulatory T cells. Nature Chemical Biology. 17(6). 711–717. 79 indexed citations

10.

Powell, Chelsea E., Guangyan Du, Jianwei Che, et al.. (2020). Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library. ACS Chemical Biology. 15(10). 2722–2730. 68 indexed citations

11.

Jiang, Baishan, Eric S. Wang, Katherine A. Donovan, et al.. (2019). Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6. Angewandte Chemie International Edition. 58(19). 6321–6326. 212 indexed citations

12.

Jiang, Baishan, Eric S. Wang, Katherine A. Donovan, et al.. (2019). Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6. Angewandte Chemie. 131(19). 6387–6392. 11 indexed citations

13.

Brand, Matthias, Baishan Jiang, Sophie Bauer, et al.. (2018). Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML. Cell chemical biology. 26(2). 300–306.e9. 195 indexed citations

14.

Hatcher, John M., Eric S. Wang, Liv Johannessen, et al.. (2018). Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8. ACS Medicinal Chemistry Letters. 9(6). 540–545. 66 indexed citations

15.

Wang, Eric S., Sara Morrow, T.B. Faust, et al.. (2018). Bruton tyrosine kinase degradation as a therapeutic strategy for cancer. Blood. 133(9). 952–961. 131 indexed citations

16.

Block, Stephanie D., et al.. (2016). Variation in Acceptable Child Discipline Practices by Child Age: Perceptions of Community Norms by Medical and Legal Professionals. Behavioral Sciences & the Law. 34(1). 95–112. 5 indexed citations

17.

Wang, Eric S., et al.. (2011). Adaptation of an ICAM-1-Tropic Enterovirus to the Mouse Respiratory Tract. Journal of Virology. 85(11). 5606–5617. 4 indexed citations

18.

Maynard, Dawn, et al.. (2006). Reexamination of the cysteine residues in glucocerebrosidase. FEBS Letters. 580(14). 3391–3394. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact